{"id":21240,"date":"2025-01-13T05:39:00","date_gmt":"2025-01-13T05:39:00","guid":{"rendered":"https:\/\/www.ttci-th.org\/?p=21240"},"modified":"2025-08-19T09:50:46","modified_gmt":"2025-08-19T09:50:46","slug":"immune-cell-engager-chemo-myeloma","status":"publish","type":"post","link":"https:\/\/www.ttci-th.org\/th\/immune-cell-engager-chemo-myeloma\/","title":{"rendered":"New Immune Cell Engager Combined with Chemotherapy Boosts Attack on Multiple Myeloma"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"21240\" class=\"elementor elementor-21240\">\n\t\t\t\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-32163b7 elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no\" data-id=\"32163b7\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-9247286\" data-id=\"9247286\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-31ef166 elementor-widget elementor-widget-text-editor\" data-id=\"31ef166\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.16.0 - 14-09-2023 *\/\n.elementor-widget-text-editor.elementor-drop-cap-view-stacked .elementor-drop-cap{background-color:#69727d;color:#fff}.elementor-widget-text-editor.elementor-drop-cap-view-framed .elementor-drop-cap{color:#69727d;border:3px solid;background-color:transparent}.elementor-widget-text-editor:not(.elementor-drop-cap-view-default) .elementor-drop-cap{margin-top:8px}.elementor-widget-text-editor:not(.elementor-drop-cap-view-default) .elementor-drop-cap-letter{width:1em;height:1em}.elementor-widget-text-editor .elementor-drop-cap{float:left;text-align:center;line-height:1;font-size:50px}.elementor-widget-text-editor .elementor-drop-cap-letter{display:inline-block}<\/style>\t\t\t\t<p>Researchers are exploring a new treatment strategy for multiple myeloma, a type of blood cancer that often becomes resistant to therapy. They found that a low dose of the chemotherapy drug bortezomib can increase a protein called PD-L1 on cancer cells. This increase in PD-L1 makes the cancer cells more visible to a new type of engineered immune cell called &#8220;bispecific \u03b1PD-L1 \u00d7 \u03b1CD3 T cell engager-armed T cells&#8221; (BATs). These BATs are designed to both block PD-L1 (preventing cancer from hiding) and activate the body&#8217;s own T cells to kill the cancer. Lab tests showed that BATs effectively killed myeloma cells, and this killing power was even stronger when combined with low-dose bortezomib. This combination approach looks promising for treating multiple myeloma, even in cases where the cancer has become resistant to bortezomib.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-6e75882 elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no\" data-id=\"6e75882\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-16220c7\" data-id=\"16220c7\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-0386e6f elementor-widget elementor-widget-spacer\" data-id=\"0386e6f\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.16.0 - 14-09-2023 *\/\n.elementor-column .elementor-spacer-inner{height:var(--spacer-size)}.e-con{--container-widget-width:100%}.e-con-inner>.elementor-widget-spacer,.e-con>.elementor-widget-spacer{width:var(--container-widget-width,var(--spacer-size));--align-self:var(--container-widget-align-self,initial);--flex-shrink:0}.e-con-inner>.elementor-widget-spacer>.elementor-widget-container,.e-con>.elementor-widget-spacer>.elementor-widget-container{height:100%;width:100%}.e-con-inner>.elementor-widget-spacer>.elementor-widget-container>.elementor-spacer,.e-con>.elementor-widget-spacer>.elementor-widget-container>.elementor-spacer{height:100%}.e-con-inner>.elementor-widget-spacer>.elementor-widget-container>.elementor-spacer>.elementor-spacer-inner,.e-con>.elementor-widget-spacer>.elementor-widget-container>.elementor-spacer>.elementor-spacer-inner{height:var(--container-widget-height,var(--spacer-size))}.e-con-inner>.elementor-widget-spacer.elementor-widget-empty,.e-con>.elementor-widget-spacer.elementor-widget-empty{position:relative;min-height:22px;min-width:22px}.e-con-inner>.elementor-widget-spacer.elementor-widget-empty .elementor-widget-empty-icon,.e-con>.elementor-widget-spacer.elementor-widget-empty .elementor-widget-empty-icon{position:absolute;top:0;bottom:0;left:0;right:0;margin:auto;padding:0;width:22px;height:22px}<\/style>\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-cb58e40 elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no\" data-id=\"cb58e40\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-22372e9\" data-id=\"22372e9\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-d30471e elementor-widget__width-initial elementor-widget elementor-widget-heading\" data-id=\"d30471e\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.16.0 - 14-09-2023 *\/\n.elementor-heading-title{padding:0;margin:0;line-height:1}.elementor-widget-heading .elementor-heading-title[class*=elementor-size-]>a{color:inherit;font-size:inherit;line-height:inherit}.elementor-widget-heading .elementor-heading-title.elementor-size-small{font-size:15px}.elementor-widget-heading .elementor-heading-title.elementor-size-medium{font-size:19px}.elementor-widget-heading .elementor-heading-title.elementor-size-large{font-size:29px}.elementor-widget-heading .elementor-heading-title.elementor-size-xl{font-size:39px}.elementor-widget-heading .elementor-heading-title.elementor-size-xxl{font-size:59px}<\/style><h2 class=\"elementor-heading-title elementor-size-default\">\u0e40\u0e07\u0e34\u0e19\u0e17\u0e38\u0e19<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-6aeec7e elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"6aeec7e\" data-element_type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.16.0 - 14-09-2023 *\/\n.elementor-widget-divider{--divider-border-style:none;--divider-border-width:1px;--divider-color:#0c0d0e;--divider-icon-size:20px;--divider-element-spacing:10px;--divider-pattern-height:24px;--divider-pattern-size:20px;--divider-pattern-url:none;--divider-pattern-repeat:repeat-x}.elementor-widget-divider .elementor-divider{display:flex}.elementor-widget-divider .elementor-divider__text{font-size:15px;line-height:1;max-width:95%}.elementor-widget-divider .elementor-divider__element{margin:0 var(--divider-element-spacing);flex-shrink:0}.elementor-widget-divider .elementor-icon{font-size:var(--divider-icon-size)}.elementor-widget-divider .elementor-divider-separator{display:flex;margin:0;direction:ltr}.elementor-widget-divider--view-line_icon .elementor-divider-separator,.elementor-widget-divider--view-line_text .elementor-divider-separator{align-items:center}.elementor-widget-divider--view-line_icon .elementor-divider-separator:after,.elementor-widget-divider--view-line_icon .elementor-divider-separator:before,.elementor-widget-divider--view-line_text .elementor-divider-separator:after,.elementor-widget-divider--view-line_text .elementor-divider-separator:before{display:block;content:\"\";border-bottom:0;flex-grow:1;border-top:var(--divider-border-width) var(--divider-border-style) var(--divider-color)}.elementor-widget-divider--element-align-left .elementor-divider .elementor-divider-separator>.elementor-divider__svg:first-of-type{flex-grow:0;flex-shrink:100}.elementor-widget-divider--element-align-left .elementor-divider-separator:before{content:none}.elementor-widget-divider--element-align-left .elementor-divider__element{margin-left:0}.elementor-widget-divider--element-align-right .elementor-divider .elementor-divider-separator>.elementor-divider__svg:last-of-type{flex-grow:0;flex-shrink:100}.elementor-widget-divider--element-align-right .elementor-divider-separator:after{content:none}.elementor-widget-divider--element-align-right .elementor-divider__element{margin-right:0}.elementor-widget-divider:not(.elementor-widget-divider--view-line_text):not(.elementor-widget-divider--view-line_icon) .elementor-divider-separator{border-top:var(--divider-border-width) var(--divider-border-style) var(--divider-color)}.elementor-widget-divider--separator-type-pattern{--divider-border-style:none}.elementor-widget-divider--separator-type-pattern.elementor-widget-divider--view-line .elementor-divider-separator,.elementor-widget-divider--separator-type-pattern:not(.elementor-widget-divider--view-line) .elementor-divider-separator:after,.elementor-widget-divider--separator-type-pattern:not(.elementor-widget-divider--view-line) .elementor-divider-separator:before,.elementor-widget-divider--separator-type-pattern:not([class*=elementor-widget-divider--view]) .elementor-divider-separator{width:100%;min-height:var(--divider-pattern-height);-webkit-mask-size:var(--divider-pattern-size) 100%;mask-size:var(--divider-pattern-size) 100%;-webkit-mask-repeat:var(--divider-pattern-repeat);mask-repeat:var(--divider-pattern-repeat);background-color:var(--divider-color);-webkit-mask-image:var(--divider-pattern-url);mask-image:var(--divider-pattern-url)}.elementor-widget-divider--no-spacing{--divider-pattern-size:auto}.elementor-widget-divider--bg-round{--divider-pattern-repeat:round}.rtl .elementor-widget-divider .elementor-divider__text{direction:rtl}.e-con-inner>.elementor-widget-divider,.e-con>.elementor-widget-divider{width:var(--container-widget-width,100%);--flex-grow:var(--container-widget-flex-grow)}<\/style>\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-86b218e elementor-widget elementor-widget-text-editor\" data-id=\"86b218e\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p>&#8211;<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-91cf715 elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no\" data-id=\"91cf715\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-67a6e53\" data-id=\"67a6e53\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-540b814 elementor-widget elementor-widget-spacer\" data-id=\"540b814\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-f5f587e elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no\" data-id=\"f5f587e\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-03bcea0\" data-id=\"03bcea0\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-ca5ef47 elementor-widget__width-initial elementor-widget elementor-widget-heading\" data-id=\"ca5ef47\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">\n\u0e01\u0e23\u0e30\u0e14\u0e32\u0e29\u0e15\u0e49\u0e19\u0e09\u0e1a\u0e31\u0e1a<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-2a9807c elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"2a9807c\" data-element_type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-89bfba8 elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"89bfba8\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p><strong>\u0e0a\u0e37\u0e48\u0e2d\u0e1a\u0e17\u0e04\u0e27\u0e32\u0e21\u0e15\u0e49\u0e19\u0e09\u0e1a\u0e31\u0e1a:<\/strong> Enhancing T cell cytotoxicity in multiple myeloma with bispecific \u03b1PD-L1 \u00d7 \u03b1CD3 T cell engager-armed T cells and low-dose bortezomib therapy<br \/><strong>\u0e27\u0e32\u0e23\u0e2a\u0e32\u0e23:<\/strong> Biomedicine &amp; Pharmacotherapy (Biomed Pharmacother)<br \/><strong>\u0e14\u0e2d\u0e22: <\/strong><a href=\"http:\/\/10.1016\/j.biopha.2025.117878\">10.1016\/j.biopha.2025.117878<\/a><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-513a232 elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no\" data-id=\"513a232\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-7709a77\" data-id=\"7709a77\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-1fc1ca7 elementor-widget elementor-widget-spacer\" data-id=\"1fc1ca7\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-5c5d082 elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no\" data-id=\"5c5d082\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-d7e3d8d\" data-id=\"d7e3d8d\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-8a45000 elementor-widget__width-initial elementor-widget elementor-widget-heading\" data-id=\"8a45000\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">\u0e08\u0e14\u0e2b\u0e21\u0e32\u0e22\u0e42\u0e15\u0e49\u0e15\u0e2d\u0e1a<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-6aa3269 elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"6aa3269\" data-element_type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-8df055a elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"8df055a\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p><strong>\u0e2d\u0e31\u0e2a\u0e2a\u0e23\u0e32\u0e1b\u0e31\u0e0d\u0e0d\u0e32<\/strong><br \/>Department of Biology, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand; Cell Engineering for Cancer Therapy Research Group, Chiang Mai University, Chiang Mai 50200, Thailand.<br \/>\u0e2d\u0e35\u0e40\u0e21\u0e25: <a href=\"mailto:aussara.pan@cmu.ac.th\">aussara.pan@cmu.ac.th<\/a><br \/><strong>Pa-Thai Yenchitsomanus<\/strong><br \/>Siriraj Center of Research Excellence for Cancer Immunotherapy (SiCORE-CIT), Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand and Division of Molecular Medicine, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.<br \/>E-mail: <a href=\"mailto:ptyench@gmail.com\">ptyench@gmail.com<\/a><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-a2a0cb4 elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no\" data-id=\"a2a0cb4\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-8067b9b\" data-id=\"8067b9b\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-235d100 elementor-widget elementor-widget-jkit_social_share\" data-id=\"235d100\" data-element_type=\"widget\" data-widget_type=\"jkit_social_share.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<div  class=\"jeg-elementor-kit jkit-social-share jeg_module___6aa5e04b19f88\" ><ul class=\"social-share-list\"><li class=\"elementor-repeater-item-14d1b21\" data-social=\"facebook\">\n\t\t\t\t<a class=\"facebook social-icon\"><span class=\"icon-position-before\"><i aria-hidden=\"true\" class=\"fab fa-facebook-f\"><\/i>\u0e40\u0e1f\u0e2a\u0e1a\u0e38\u0e4a\u0e04<\/span><\/a>\n\t\t\t<\/li><li class=\"elementor-repeater-item-ee9a855\" data-social=\"twitter\">\n\t\t\t\t<a class=\"twitter social-icon\"><span class=\"icon-position-before\"><i aria-hidden=\"true\" class=\"fab fa-twitter\"><\/i>\u0e17\u0e27\u0e34\u0e15\u0e40\u0e15\u0e2d\u0e23\u0e4c<\/span><\/a>\n\t\t\t<\/li><li class=\"elementor-repeater-item-4a6d796\" data-social=\"line\">\n\t\t\t\t<a class=\"line social-icon\"><span class=\"icon-position-before\"><i aria-hidden=\"true\" class=\"fab fa-line\"><\/i>\u0e40\u0e2a\u0e49\u0e19<\/span><\/a>\n\t\t\t<\/li><\/ul><\/div>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>Researchers are exploring a new treatment strategy for multiple myeloma, a type of blood cancer that often becomes resistant to therapy. They found that a low dose of the chemotherapy drug bortezomib can increase a protein called PD-L1 on cancer cells. This increase in PD-L1 makes the cancer cells more visible to a new type&#8230;<\/p>","protected":false},"author":4,"featured_media":20345,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[178,105],"tags":[180,101],"class_list":["post-21240","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-research-news-cmu","category-research-news-research-news","tag-tag-topic-cmu","tag-tag-topic-mu"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.1.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"Researchers are exploring a new treatment strategy for multiple myeloma, a type of blood cancer that often becomes resistant to therapy. They found that a low dose of the chemotherapy drug bortezomib can increase a protein called PD-L1 on cancer cells. This increase in PD-L1 makes the cancer cells more visible to a new type\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"admin@narisara\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.ttci-th.org\/th\/immune-cell-engager-chemo-myeloma\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.1.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"th_TH\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Thailand Hub of Talents in Cancer Immunotherapy (TTCI Thailand) - TTCI-TH\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"New Immune Cell Engager Combined with Chemotherapy Boosts Attack on Multiple Myeloma\" \/>\n\t\t<meta property=\"og:description\" content=\"Researchers are exploring a new treatment strategy for multiple myeloma, a type of blood cancer that often becomes resistant to therapy. They found that a low dose of the chemotherapy drug bortezomib can increase a protein called PD-L1 on cancer cells. This increase in PD-L1 makes the cancer cells more visible to a new type\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.ttci-th.org\/th\/immune-cell-engager-chemo-myeloma\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2024\/07\/Blue-and-Orange-Modern-Technology-Innovation-and-Information-Systems-Presentation.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2024\/07\/Blue-and-Orange-Modern-Technology-Innovation-and-Information-Systems-Presentation.png\" \/>\n\t\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2025-01-13T05:39:00+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2025-08-19T09:50:46+00:00\" \/>\n\t\t<meta property=\"article:publisher\" content=\"https:\/\/web.facebook.com\/ttci.th\/\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:site\" content=\"@ttci_th\" \/>\n\t\t<meta name=\"twitter:title\" content=\"New Immune Cell Engager Combined with Chemotherapy Boosts Attack on Multiple Myeloma\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Researchers are exploring a new treatment strategy for multiple myeloma, a type of blood cancer that often becomes resistant to therapy. They found that a low dose of the chemotherapy drug bortezomib can increase a protein called PD-L1 on cancer cells. This increase in PD-L1 makes the cancer cells more visible to a new type\" \/>\n\t\t<meta name=\"twitter:creator\" content=\"@ttci_th\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2023\/05\/cropped-cropped-TTCI_LOGO__PNG_-001-removebg-preview.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/immune-cell-engager-chemo-myeloma\\\/#blogposting\",\"name\":\"New Immune Cell Engager Combined with Chemotherapy Boosts Attack on Multiple Myeloma\",\"headline\":\"New Immune Cell Engager Combined with Chemotherapy Boosts Attack on Multiple Myeloma\",\"author\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/author\\\/adminnarisara\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.ttci-th.org\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/Blue-and-Orange-Modern-Technology-Innovation-and-Information-Systems-Presentation.png\",\"width\":1200,\"height\":675},\"datePublished\":\"2025-01-13T05:39:00+00:00\",\"dateModified\":\"2025-08-19T09:50:46+00:00\",\"inLanguage\":\"th\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/immune-cell-engager-chemo-myeloma\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/immune-cell-engager-chemo-myeloma\\\/#webpage\"},\"articleSection\":\"Chiang Mai University, Mahidol University, Chiang Mai University, Mahidol University\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/immune-cell-engager-chemo-myeloma\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.ttci-th.org\\\/th\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/category\\\/research-news\\\/#listItem\",\"name\":\"Research News\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/category\\\/research-news\\\/#listItem\",\"position\":2,\"name\":\"Research News\",\"item\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/category\\\/research-news\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/category\\\/research-news\\\/research-news-research-news\\\/#listItem\",\"name\":\"Mahidol University\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/category\\\/research-news\\\/research-news-research-news\\\/#listItem\",\"position\":3,\"name\":\"Mahidol University\",\"item\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/category\\\/research-news\\\/research-news-research-news\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/immune-cell-engager-chemo-myeloma\\\/#listItem\",\"name\":\"New Immune Cell Engager Combined with Chemotherapy Boosts Attack on Multiple Myeloma\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/category\\\/research-news\\\/#listItem\",\"name\":\"Research News\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/immune-cell-engager-chemo-myeloma\\\/#listItem\",\"position\":4,\"name\":\"New Immune Cell Engager Combined with Chemotherapy Boosts Attack on Multiple Myeloma\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/category\\\/research-news\\\/research-news-research-news\\\/#listItem\",\"name\":\"Mahidol University\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/#organization\",\"name\":\"Thailand Hub of Talents in Cancer Immunotherapy\",\"description\":\"TTCI-TH\",\"url\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.ttci-th.org\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/cropped-cropped-TTCI_LOGO__PNG_-001-removebg-preview.png\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/immune-cell-engager-chemo-myeloma\\\/#organizationLogo\",\"width\":512,\"height\":512},\"image\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/immune-cell-engager-chemo-myeloma\\\/#organizationLogo\"},\"sameAs\":[\"https:\\\/\\\/web.facebook.com\\\/ttci.th\\\/\",\"https:\\\/\\\/www.twitter.com\\\/ttci_th\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/author\\\/adminnarisara\\\/#author\",\"url\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/author\\\/adminnarisara\\\/\",\"name\":\"admin@narisara\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/immune-cell-engager-chemo-myeloma\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/75b4fa1780d4337192829073b76451e4e65b3d665abf974c24531ee7367104a4?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"admin@narisara\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/immune-cell-engager-chemo-myeloma\\\/#webpage\",\"url\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/immune-cell-engager-chemo-myeloma\\\/\",\"name\":\"New Immune Cell Engager Combined with Chemotherapy Boosts Attack on Multiple Myeloma\",\"description\":\"Researchers are exploring a new treatment strategy for multiple myeloma, a type of blood cancer that often becomes resistant to therapy. They found that a low dose of the chemotherapy drug bortezomib can increase a protein called PD-L1 on cancer cells. This increase in PD-L1 makes the cancer cells more visible to a new type\",\"inLanguage\":\"th\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/immune-cell-engager-chemo-myeloma\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/author\\\/adminnarisara\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/author\\\/adminnarisara\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.ttci-th.org\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/Blue-and-Orange-Modern-Technology-Innovation-and-Information-Systems-Presentation.png\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/immune-cell-engager-chemo-myeloma\\\/#mainImage\",\"width\":1200,\"height\":675},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/immune-cell-engager-chemo-myeloma\\\/#mainImage\"},\"datePublished\":\"2025-01-13T05:39:00+00:00\",\"dateModified\":\"2025-08-19T09:50:46+00:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/#website\",\"url\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/\",\"name\":\"Thailand Hub of Talents in Cancer Immunotherapy\",\"description\":\"TTCI-TH\",\"inLanguage\":\"th\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"New Immune Cell Engager Combined with Chemotherapy Boosts Attack on Multiple Myeloma","description":"Researchers are exploring a new treatment strategy for multiple myeloma, a type of blood cancer that often becomes resistant to therapy. They found that a low dose of the chemotherapy drug bortezomib can increase a protein called PD-L1 on cancer cells. This increase in PD-L1 makes the cancer cells more visible to a new type","canonical_url":"https:\/\/www.ttci-th.org\/th\/immune-cell-engager-chemo-myeloma\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/www.ttci-th.org\/th\/immune-cell-engager-chemo-myeloma\/#blogposting","name":"New Immune Cell Engager Combined with Chemotherapy Boosts Attack on Multiple Myeloma","headline":"New Immune Cell Engager Combined with Chemotherapy Boosts Attack on Multiple Myeloma","author":{"@id":"https:\/\/www.ttci-th.org\/th\/author\/adminnarisara\/#author"},"publisher":{"@id":"https:\/\/www.ttci-th.org\/th\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2024\/07\/Blue-and-Orange-Modern-Technology-Innovation-and-Information-Systems-Presentation.png","width":1200,"height":675},"datePublished":"2025-01-13T05:39:00+00:00","dateModified":"2025-08-19T09:50:46+00:00","inLanguage":"th","mainEntityOfPage":{"@id":"https:\/\/www.ttci-th.org\/th\/immune-cell-engager-chemo-myeloma\/#webpage"},"isPartOf":{"@id":"https:\/\/www.ttci-th.org\/th\/immune-cell-engager-chemo-myeloma\/#webpage"},"articleSection":"Chiang Mai University, Mahidol University, Chiang Mai University, Mahidol University"},{"@type":"BreadcrumbList","@id":"https:\/\/www.ttci-th.org\/th\/immune-cell-engager-chemo-myeloma\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.ttci-th.org\/th#listItem","position":1,"name":"Home","item":"https:\/\/www.ttci-th.org\/th","nextItem":{"@type":"ListItem","@id":"https:\/\/www.ttci-th.org\/th\/category\/research-news\/#listItem","name":"Research News"}},{"@type":"ListItem","@id":"https:\/\/www.ttci-th.org\/th\/category\/research-news\/#listItem","position":2,"name":"Research News","item":"https:\/\/www.ttci-th.org\/th\/category\/research-news\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.ttci-th.org\/th\/category\/research-news\/research-news-research-news\/#listItem","name":"Mahidol University"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.ttci-th.org\/th#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/www.ttci-th.org\/th\/category\/research-news\/research-news-research-news\/#listItem","position":3,"name":"Mahidol University","item":"https:\/\/www.ttci-th.org\/th\/category\/research-news\/research-news-research-news\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.ttci-th.org\/th\/immune-cell-engager-chemo-myeloma\/#listItem","name":"New Immune Cell Engager Combined with Chemotherapy Boosts Attack on Multiple Myeloma"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.ttci-th.org\/th\/category\/research-news\/#listItem","name":"Research News"}},{"@type":"ListItem","@id":"https:\/\/www.ttci-th.org\/th\/immune-cell-engager-chemo-myeloma\/#listItem","position":4,"name":"New Immune Cell Engager Combined with Chemotherapy Boosts Attack on Multiple Myeloma","previousItem":{"@type":"ListItem","@id":"https:\/\/www.ttci-th.org\/th\/category\/research-news\/research-news-research-news\/#listItem","name":"Mahidol University"}}]},{"@type":"Organization","@id":"https:\/\/www.ttci-th.org\/th\/#organization","name":"Thailand Hub of Talents in Cancer Immunotherapy","description":"TTCI-TH","url":"https:\/\/www.ttci-th.org\/th\/","logo":{"@type":"ImageObject","url":"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2023\/05\/cropped-cropped-TTCI_LOGO__PNG_-001-removebg-preview.png","@id":"https:\/\/www.ttci-th.org\/th\/immune-cell-engager-chemo-myeloma\/#organizationLogo","width":512,"height":512},"image":{"@id":"https:\/\/www.ttci-th.org\/th\/immune-cell-engager-chemo-myeloma\/#organizationLogo"},"sameAs":["https:\/\/web.facebook.com\/ttci.th\/","https:\/\/www.twitter.com\/ttci_th\/"]},{"@type":"Person","@id":"https:\/\/www.ttci-th.org\/th\/author\/adminnarisara\/#author","url":"https:\/\/www.ttci-th.org\/th\/author\/adminnarisara\/","name":"admin@narisara","image":{"@type":"ImageObject","@id":"https:\/\/www.ttci-th.org\/th\/immune-cell-engager-chemo-myeloma\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/75b4fa1780d4337192829073b76451e4e65b3d665abf974c24531ee7367104a4?s=96&d=mm&r=g","width":96,"height":96,"caption":"admin@narisara"}},{"@type":"WebPage","@id":"https:\/\/www.ttci-th.org\/th\/immune-cell-engager-chemo-myeloma\/#webpage","url":"https:\/\/www.ttci-th.org\/th\/immune-cell-engager-chemo-myeloma\/","name":"New Immune Cell Engager Combined with Chemotherapy Boosts Attack on Multiple Myeloma","description":"Researchers are exploring a new treatment strategy for multiple myeloma, a type of blood cancer that often becomes resistant to therapy. They found that a low dose of the chemotherapy drug bortezomib can increase a protein called PD-L1 on cancer cells. This increase in PD-L1 makes the cancer cells more visible to a new type","inLanguage":"th","isPartOf":{"@id":"https:\/\/www.ttci-th.org\/th\/#website"},"breadcrumb":{"@id":"https:\/\/www.ttci-th.org\/th\/immune-cell-engager-chemo-myeloma\/#breadcrumblist"},"author":{"@id":"https:\/\/www.ttci-th.org\/th\/author\/adminnarisara\/#author"},"creator":{"@id":"https:\/\/www.ttci-th.org\/th\/author\/adminnarisara\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2024\/07\/Blue-and-Orange-Modern-Technology-Innovation-and-Information-Systems-Presentation.png","@id":"https:\/\/www.ttci-th.org\/th\/immune-cell-engager-chemo-myeloma\/#mainImage","width":1200,"height":675},"primaryImageOfPage":{"@id":"https:\/\/www.ttci-th.org\/th\/immune-cell-engager-chemo-myeloma\/#mainImage"},"datePublished":"2025-01-13T05:39:00+00:00","dateModified":"2025-08-19T09:50:46+00:00"},{"@type":"WebSite","@id":"https:\/\/www.ttci-th.org\/th\/#website","url":"https:\/\/www.ttci-th.org\/th\/","name":"Thailand Hub of Talents in Cancer Immunotherapy","description":"TTCI-TH","inLanguage":"th","publisher":{"@id":"https:\/\/www.ttci-th.org\/th\/#organization"}}]},"og:locale":"th_TH","og:site_name":"Thailand Hub of Talents in Cancer Immunotherapy (TTCI Thailand) - TTCI-TH","og:type":"article","og:title":"New Immune Cell Engager Combined with Chemotherapy Boosts Attack on Multiple Myeloma","og:description":"Researchers are exploring a new treatment strategy for multiple myeloma, a type of blood cancer that often becomes resistant to therapy. They found that a low dose of the chemotherapy drug bortezomib can increase a protein called PD-L1 on cancer cells. This increase in PD-L1 makes the cancer cells more visible to a new type","og:url":"https:\/\/www.ttci-th.org\/th\/immune-cell-engager-chemo-myeloma\/","og:image":"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2024\/07\/Blue-and-Orange-Modern-Technology-Innovation-and-Information-Systems-Presentation.png","og:image:secure_url":"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2024\/07\/Blue-and-Orange-Modern-Technology-Innovation-and-Information-Systems-Presentation.png","og:image:width":"1200","og:image:height":"675","article:published_time":"2025-01-13T05:39:00+00:00","article:modified_time":"2025-08-19T09:50:46+00:00","article:publisher":"https:\/\/web.facebook.com\/ttci.th\/","twitter:card":"summary_large_image","twitter:site":"@ttci_th","twitter:title":"New Immune Cell Engager Combined with Chemotherapy Boosts Attack on Multiple Myeloma","twitter:description":"Researchers are exploring a new treatment strategy for multiple myeloma, a type of blood cancer that often becomes resistant to therapy. They found that a low dose of the chemotherapy drug bortezomib can increase a protein called PD-L1 on cancer cells. This increase in PD-L1 makes the cancer cells more visible to a new type","twitter:creator":"@ttci_th","twitter:image":"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2023\/05\/cropped-cropped-TTCI_LOGO__PNG_-001-removebg-preview.png"},"aioseo_meta_data":{"post_id":"21240","title":"#post_title","description":null,"keywords":[],"keyphrases":{"focus":{"keyphrase":"immune cell ","score":75,"analysis":{"keyphraseInTitle":{"score":9,"maxScore":9,"error":0},"keyphraseInDescription":{"score":9,"maxScore":9,"error":0},"keyphraseLength":{"score":9,"maxScore":9,"error":0,"length":2},"keyphraseInURL":{"score":5,"maxScore":5,"error":0},"keyphraseInIntroduction":{"score":9,"maxScore":9,"error":0},"keyphraseInSubHeadings":{"score":3,"maxScore":9,"error":1},"keyphraseInImageAlt":[],"keywordDensity":{"score":0,"type":"low","maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"featured","og_image_url":"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2024\/07\/Blue-and-Orange-Modern-Technology-Innovation-and-Information-Systems-Presentation.png","og_image_width":"1200","og_image_height":"675","og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":[],"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"BlogPosting","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"limit_modified_date":false,"created":"2025-08-10 05:45:32","updated":"2026-09-03 07:18:47","focus_keyword":"immune cell","additional_keywords":null,"truseo_locale":null,"ai":null,"breadcrumb_settings":null,"seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.ttci-th.org\/th\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.ttci-th.org\/th\/category\/research-news\/\" title=\"Research News\">Research News<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.ttci-th.org\/th\/category\/research-news\/research-news-research-news\/\" title=\"Mahidol University\">Mahidol University<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tNew Immune Cell Engager Combined with Chemotherapy Boosts Attack on Multiple Myeloma\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.ttci-th.org\/th"},{"label":"Research News","link":"https:\/\/www.ttci-th.org\/th\/category\/research-news\/"},{"label":"Mahidol University","link":"https:\/\/www.ttci-th.org\/th\/category\/research-news\/research-news-research-news\/"},{"label":"New Immune Cell Engager Combined with Chemotherapy Boosts Attack on Multiple Myeloma","link":"https:\/\/www.ttci-th.org\/th\/immune-cell-engager-chemo-myeloma\/"}],"_links":{"self":[{"href":"https:\/\/www.ttci-th.org\/th\/wp-json\/wp\/v2\/posts\/21240","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ttci-th.org\/th\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ttci-th.org\/th\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ttci-th.org\/th\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ttci-th.org\/th\/wp-json\/wp\/v2\/comments?post=21240"}],"version-history":[{"count":0,"href":"https:\/\/www.ttci-th.org\/th\/wp-json\/wp\/v2\/posts\/21240\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ttci-th.org\/th\/wp-json\/wp\/v2\/media\/20345"}],"wp:attachment":[{"href":"https:\/\/www.ttci-th.org\/th\/wp-json\/wp\/v2\/media?parent=21240"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ttci-th.org\/th\/wp-json\/wp\/v2\/categories?post=21240"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ttci-th.org\/th\/wp-json\/wp\/v2\/tags?post=21240"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}